Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis

키워드

참고문헌 (38)

1. Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease : meta-analytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)
2. Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
3. Angulo P, "Obesity and nonalcoholic fatty liver disease", Nutr Rev, 65(6 Pt 2), pp.S57~S63 (2007)
4. 정찬희, "Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis", Endocrinology and Metabolism, 35(1), pp.165~176 (2020), 대한내분비학회
5. 이민경, "Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study", Endocrinology and Metabolism, 30(4), pp.522~530 (2015), 대한내분비학회
6. Fielding RA, "Sarcopenia : an undiagnosed condition in older adults : current consensus definition : prevalence, etiology, and consequences. International working group on sarcopenia", J Am Med Dir Assoc, 12, pp.249~256 (2011)
7. Kim TN, "The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease", J Cell Biochem, 116, pp.1171~1178 (2015)
8. Issa D, "Presence of sarcopenia(muscle wasting)in patients with nonalcoholic steatohepatitis", Hepatology, 60, pp.428~429 (2014)
9. Wijarnpreecha K, "Association between sarcopenic obesity and nonalcoholic fatty liver disease and fibrosis detected by Fibroscan", J Gastrointestin Liver Dis, 30, pp.227~232 (2021)
10. Chen LK, "Recent advances in sarcopenia research in Asia : 2016 update from the Asian Working Group for Sarcopenia", J Am Med Dir Assoc, 17, pp.767~ (2016)
11. Janssen I, "Low relative skeletal muscle mass(sarcopenia)in older persons is associated with functional impairment and physical disability", J Am Geriatr Soc, 50, pp.889~896 (2002)
12. 임희숙, "Association between Sarcopenia, Sarcopenic Obesity, and Chronic Disease in Korean Elderly", 대한골대사학회지, 25(3), pp.187~193 (2018), 대한골대사학회[DOI]
13. Lim S, "Sarcopenic obesity : prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging(KLoSHA)", Diabetes Care, 33, pp.1652~1654 (2010)
14. Kim TN, "Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study", Clin Endocrinol(Oxf), 78, pp.525~532 (2013)
15. Prado CM, "Sarcopenic obesity : a critical appraisal of the current evidence", Clin Nutr, 31, pp.583~601 (2012)
16. Upadhya B, "Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction", Curr Heart Fail Rep, 12, pp.205~214 (2015)
17. Jung KS, "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement(FibroScan)", Hepatology, 53, pp.885~894 (2011)
18. Kim MN, "Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis", Hepatology, 61, pp.1851~1859 (2015)
19. Sasso M, "Controlled attenuation parameter(CAP) : a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis : preliminary study and validation in a cohort of patients with chronic liver disease from various causes", Ultrasound Med Biol, 36, pp.1825~1835 (2010)
20. Yen YH, "Using controlled attenuation parameter combined with ultrasound to survey nonalcoholic fatty liver disease in hemodialysis patients : a prospective cohort study", PLoS One, 12, pp.e0176027~ (2017)
21. Lupșor-Platon M, "Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis : a prospective study", J Gastrointestin Liver Dis, 24, pp.35~42 (2015)
22. Mikolasevic I, "Transient elastography(FibroScan(Ⓡ))with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease : where do we stand?", World J Gastroenterol, 22, pp.7236~7251 (2016)
23. Eddowes PJ, "Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease", Gastroenterology, 156, pp.1717~1730 (2019)
24. Imanirad D, "Institutional review of utilization of vibration-controlled transient elastography(FibroScan)in evaluation of non alcoholic fatty liver disease", Am J Gastroenterol, 113, pp.S583~S584 (2018)
25. Silva Neto LS, "Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women", Rev Bras Fisioter, 16, pp.360~367 (2012)
26. Yang KC, "Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance", Sci Rep, 6, pp.27034~ (2016)
27. Hong SH, "Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences", Int J Mol Sci, 21, pp.494~ (2020)
28. Yoo JH, "Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in Korean adults", Diabetes Metab Res Rev, 37, pp.e3363~ (2021)
29. Han A, "Diagnostic criteria and clinical outcomes in sarcopenia research : a literature review", J Clin Med, 7, pp.70~ (2018)
30. 성민제, "Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus", Gut and Liver, 14(5), pp.626~635 (2020), 거트앤리버 소화기연관학회협의회[DOI]
31. Shoelson SE, "Obesity, inflammation, and insulin resistance", Gastroenterology, 132, pp.2169~2180 (2007)
32. Talbot NA, "Obesity, inflammation and insulin resistance in skeletal muscle", Ph.D., pp.2014
33. Angulo P, "Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease", J Hepatol, 41, pp.943~949 (2004)
34. Marchesini G, "Association of nonalcoholic fatty liver disease with insulin resistance", Am J Med, 107, pp.450~455 (1999)
35. Czaja AJ, "Hepatic inflammation and progressive liver fibrosis in chronic liver disease", World J Gastroenterol, 20, pp.2515~2532 (2014)
36. Duarte N, "How inflammation impinges on NAFLD : a role for Kupffer cells", Biomed Res Int, 2015, pp.984578~ (2015)
37. Goossens GH, "The metabolic phenotype in obesity : fat mass, body fat distribution, and adipose tissue function", Obes Facts, 10, pp.207~215 (2017)
38. Engin A, "The definition and prevalence of obesity and metabolic syndrome", Adv Exp Med Biol, 960, pp.1~17 (2017)

관련 논문AI추천